ScoreWhy is Jeevan Scientific Technology Ltd ?
1
Weak Long Term Fundamental Strength with a -16.28% CAGR growth in Operating Profits over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 1.37
- The company has been able to generate a Return on Equity (avg) of 4.78% signifying low profitability per unit of shareholders funds
2
With a growth in Net Sales of 107.73%, the company declared Very Positive results in Jun 26
- The company has declared positive results for the last 3 consecutive quarters
- NET SALES(9M) Higher at Rs 58.64 cr
- PAT(9M) Higher at Rs 3.57 Cr
- CASH AND CASH EQUIVALENTS(HY) Highest at Rs 9.51 cr
3
With ROCE of 3.8, it has a Attractive valuation with a 1.9 Enterprise value to Capital Employed
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 90.33%, its profits have risen by 185.9% ; the PEG ratio of the company is 0.3
4
Majority shareholders : Non Institution
5
Market Beating Performance
- The stock has generated a return of 90.33% in the last 1 year, much higher than market (BSE500) returns of 2.66%
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Jeevan Scienti. should be less than 10%
- Overall Portfolio exposure to Healthcare Services should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Healthcare Services)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Jeevan Scienti. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Jeevan Scienti.
90.3%
1.99
45.36%
Sensex
-4.23%
-0.30
13.42%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
3.87%
EBIT Growth (5y)
-16.28%
EBIT to Interest (avg)
1.37
Debt to EBITDA (avg)
3.60
Net Debt to Equity (avg)
0.16
Sales to Capital Employed (avg)
0.79
Tax Ratio
24.71%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
12.19%
ROE (avg)
4.78%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
42
Industry P/E
37
Price to Book Value
2.02
EV to EBIT
19.71
EV to EBITDA
10.78
EV to Capital Employed
1.87
EV to Sales
2.21
PEG Ratio
0.25
Dividend Yield
NA
ROCE (Latest)
3.81%
ROE (Latest)
-0.22%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend24What is working for the Company
NET SALES(9M)
Higher at Rs 58.64 cr
PAT(9M)
Higher at Rs 3.57 Cr
CASH AND CASH EQUIVALENTS(HY)
Highest at Rs 9.51 cr
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Jeevan Scienti.
Profit After Tax (PAT) - Latest six months
At Rs 2.15 cr has Grown at 148.86%
Year on Year (YoY)MOJO Watch
PAT trend is very positive
PAT (Rs Cr)
Net Sales - Quarterly
At Rs 18.28 cr has Grown at 107.73%
Year on Year (YoY)MOJO Watch
Near term sales trend is very positive
Net Sales (Rs Cr)
Profit After Tax (PAT) - Latest six months
Higher at Rs 2.15 cr
than preceding 12 month period ended Jun 2026 of Rs -3.07 crMOJO Watch
In the half year the company has already crossed PAT of the previous twelve months
PAT (Rs Cr)
Cash and Cash Equivalents - Half Yearly
Highest at Rs 9.51 cr
in the last six half yearly periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
